The newly launched cancer therapy startup plans to initiate clinical trials this year after securing funding from Alexandria Real Estate Equities’ venture arm.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

Biopolymer material decontamination company Karamedica and genomic sequencing provider Murrieta Genomics have both joined UC Riverside's newly-launched Life Sciences Incubator.

Partners Healthcare-backed precision oncology drug developer Scorpion has now raised a total of $270m in funding in the past year.

BioMérieux's molecular cancer diagnosis spinoff has agreed to a $230m purchase by women's health-focused Hologic.

Boston Scientific-backed pain cessation implant developer Neuros has secured $38m in a round co-led by Sectoral Asset Management and Amzak Health.

Dignity Health has exited OrthoSensor after the medical sensor technology provider was acquired by Stryker for an undiclosed sum.

Oxford Immunotec is set to return to private ownership in a $591m acquisition deal.